Why Partnering with Us?

MBI Pharma has extremely close working relationships with all of the key players in the Israeli Pharma market; building & implementing brand maximization strategies for our key products, working successfully and closely with both government bodies and all major sick funds (HMO), with hospitals & community health professionals as well as Opinion Leader (KOL) across therapeutic areas.

Integral to MBI Pharma is our pluridisciplinary and highly professional team with seasoned professionals from both Israeli and European backgrounds, with successful experience in international and local companies as well in as local sick funds (HMO). By choosing to work with us, our partners can have the level of confidence that their products will always be promoted in the most effective way, whatever their size and their level of complexity.

As a specialist pharmaceutical company, MBI Pharma delivers rapid registration processes, introduction & maximization of new and mature pharmaceutical products to the Israeli market place. MBI currently sells more than 500 different unlicensed medicines as well as several registered medicines to the major sick funds and government hospitals in Israel.

MBI Pharma brings you a solid experience and capacities in marketing and sales, with a proven track record of:

  • Successful product launches – from hospital products to niche and orphan drugs.
  • Market access – thanks to our team in charge of formularies management and reimbursement.
  • Shorter time to market – faster drug registration and marketing approval.

MBI Pharma is an approved importer by the Israeli Ministry of Health (MoH) and uses Israel’s leading wholesaler – NOVOLOG – to store & distribute our products.